Results 211 to 220 of about 561,224 (341)
Objective The phase 3 MANDARA study demonstrated noninferiority of benralizumab versus mepolizumab for remission in patients with eosinophilic granulomatosis with polyangiitis (EGPA). More benralizumab‐treated patients achieved complete withdrawal of oral glucocorticoids (OGCs).
Parameswaran K. Nair +14 more
wiley +1 more source
Reflections in focus: a qualitative Photovoice-informed study on pediatric patient and caregiver hospital experiences. [PDF]
Ekman FK +11 more
europepmc +1 more source
Caregiving experiences of informal caregivers
Met de vergrijzing en de veranderingen in de langdurige zorg neemt het belang van mantelzorg toe. Met de toenemende druk op mantelzorgers is inzicht noodzakelijk in zowel de omstandigheden waarin het verlenen van mantelzorg als belastend of negatief wordt ervaren, als in de omstandigheden waarin mantelzorgers juist positieve mantelzorgervaringen hebben,
openaire +1 more source
The Relationship between Caregiver Burden and Family Functioning among the Family Caregivers of Hemodialysis Patients: A Descriptive-correlational Study. [PDF]
Panahi Joda M +5 more
europepmc +1 more source
Objective Juvenile idiopathic arthritis (JIA) is associated with impaired overall health‐related quality of life (HRQoL). We evaluated the impact of tofacitinib on patient‐reported outcomes (PROs) in patients with JIA. Methods This was a post hoc analysis of a phase 3, randomized, double‐blind, placebo‐controlled withdrawal trial (NCT02592434) in ...
Hermine I. Brunner +21 more
wiley +1 more source
Parental quality of life and its influence on health-related quality of life in children with type 1 diabetes: a cross-sectional dyadic study in a multi-ethnic cohort. [PDF]
Lin J +4 more
europepmc +1 more source
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate‐to‐severe SLE activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly for 52 weeks (1:1 ...
Susan Manzi +12 more
wiley +1 more source
Family Decision to Immunize Against Respiratory Syncytial Virus and Associations with Seasonal Influenza and COVID-19 Vaccination. [PDF]
Kaye LD +7 more
europepmc +1 more source

